Description
Thymulin exerts its effects by interacting with specific receptors on immune cells, particularly T lymphocytes, which play a crucial role in orchestrating the body’s immune response. By binding to its receptors, thymulin helps regulate the proliferation, differentiation, and function of T cells, thereby modulating immune activity. Additionally, thymulin is involved in the maintenance of immune tolerance and the prevention of autoimmune reactions.
The primary benefit of thymulin lies in its ability to modulate immune function and promote immune homeostasis. Research suggests that thymulin supplementation may enhance immune responses, improve immune surveillance against pathogens, and support immune system integrity. Additionally, thymulin has been investigated for its potential therapeutic applications in immune-related disorders, such as autoimmune diseases, immunodeficiency syndromes, and age-related immune decline.
Inflammation induced by [gram-negative bacteria] LPS resulted in accumulation of several plasma pro-inflammatory cytokines, IL-1 beta, IL-2, IL-6, TNF-alpha, interferon-gamma, and also IL-10, anti-inflammatory cytokine. Thymulin previously injected in dose of 15 microg/100 g body weight, prevented the accumulation of proinflammatory cytokines in plasma.
